Source recordFED

Bold Therapeutics Inc.

Federal grants & contributions· Industrial Research Assistance Program – Contributions to Firms· National Research Council Canada· FY2023· $740,700· BN 748003712· BC

Description

The project goal is to build and validate a screening platform for identification of metal-based anticancer therapeutics with unique and promising characteristics for subsequent development.

Amendment chain · 4 entries

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $570,700 at start, $740,700 after amendment #5 (+$170,000).

$740,700$0Original · 2022-10-01 (start date) · total $570,700Amendment 3 · 2024-03-11 · total $676,700Amendment 4 · 2024-06-26 · total $676,700Amendment 5 · 2024-09-26 · total $740,700
  • #02022-10-01$570,700
  • #32024-03-11$676,700+$106,000
  • #42024-06-26$676,700
  • #52024-09-26$740,700+$64,000
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2022-10-01(start date)$570,700—The project goal is to build and validate a screening platform for identification of metal-based anticancer th…
#3 amendment2024-03-11$676,700+$106,000The project goal is to build and validate a screening platform for identification of metal-based anticancer th…
#4 amendment2024-06-26$676,700+$0The project goal is to build and validate a screening platform for identification of metal-based anticancer th…
#5 amendment2024-09-26$740,700+$64,000The project goal is to build and validate a screening platform for identification of metal-based anticancer th…

Related records · 11

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (business number 748003712)

RefDepartment · programCurrent valueFY
172-2025-2026-Q4-1038281National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program$75,000FY2026
172-2024-2025-Q4-1028202National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Youth Employment Program$30,000FY2025
172-2023-2024-Q3-1013318National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms$24,580FY2024
172-2022-2023-Q4-1001187National Research Council Canada | Conseil national de recherches Canada · CanExport Innovation$18,097FY2023
172-2022-2023-Q3-993126National Research Council Canada | Conseil national de recherches Canada · CanExport Innovation$13,658FY2023
172-2021-2022-Q2-977778National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Youth Employment Program$36,000FY2022

Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)

RefRecipientFiscal yearCurrent valueFY
172-2025-2026-Q2-1034675Mediphage Bioceuticals, Inc.FY2027$63,380FY2027
172-2025-2026-Q3-1037522OBKIO INC.FY2026$50,000FY2026
172-2025-2026-Q3-1037889SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INCFY2026$25,000FY2026
172-2025-2026-Q2-1034040Griffith Foods LimitedFY2026$54,880FY2026
172-2025-2026-Q3-1037273Apollo Machine & Welding Ltd.FY2026$230,000FY2026

Cite as: Glassbox record view · Federal grants & contributions · 172-2022-2023-Q3-997677 · retrieved 2026-11-12.